EGFR and non-small cell lung carcinoma: To evaluate its role, we assessed the effects of USP54 deletion on gefitinib-induced EGFR ubiquitination and cell cycle arrest in the gefitinib-resistant NSCLC cell lines PC9/GR and HCC827/GR.